AETHLON MEDICAL INC
AEMDOther · Non-accelerated filer<br>Smaller reporting company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | $0 | $574,245 | $294,165 | $659,104 | $650,187 |
| Operating income | −$9.3M | −$12.6M | −$11.9M | −$10.4M | −$7.9M | −$5.9M |
| Net income | −$13.4M | −$12.2M | −$12.0M | −$10.4M | −$7.9M | −$6.4M |
| Total assets | $7.4M | $8.2M | $17.5M | $19.4M | $10.7M | $10.4M |
| Total liabilities | $2.2M | $2.5M | $2.4M | $2.4M | $1.4M | $1.1M |
| Equity | $5.1M | $5.8M | $15.1M | $17.0M | $9.4M | $9.4M |
| EPS (diluted) | $-8.58 | $-38.87 | $-5.86 | $-0.71 | — | — |
| Shares out. | 2.6M | 13.9M | 24.8M | 15.8M | 15.4M | 12.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −261.3%
- Return on assets
- −181.9%
- Return on capital (ROCE)
- −171.1%
- Liabilities / assets
- 30.4%
- Debt / equity
- 0.44×
- Book value / share
- $1.98
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -76.91distress
- Accruals / assets
- −78.0%clean
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Jun 30, 2014
- NT 10-Kmissed a reporting deadline ↗Jul 1, 2013
- NT 10-Qmissed a reporting deadline ↗Feb 14, 2012
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2011
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2011
- NT 10-Kmissed a reporting deadline ↗Jun 30, 2011
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Rossetti AngelaDirector | Apr 17, 2026 | Grant | 21,815 | $2.29 |
| Shah ChetanDirector | Apr 17, 2026 | Grant | 21,815 | $2.29 |
| Broenniman Edward GDirector | Apr 17, 2026 | Grant | 21,815 | $2.29 |
| Gikakis NicolasDirector | Apr 17, 2026 | Grant | 21,815 | $2.29 |
| Shah ChetanDirector | Mar 31, 2026 | Tax withholding | 178 | $2.19 |
| Gikakis NicolasDirector | Mar 31, 2026 | Tax withholding | 178 | $2.19 |
| Broenniman Edward GDirector | Mar 31, 2026 | Tax withholding | 89 | $2.19 |
| Shah ChetanDirector | Dec 31, 2025 | Tax withholding | 179 | $2.77 |
| Gikakis NicolasDirector | Dec 31, 2025 | Tax withholding | 179 | $2.77 |
| Broenniman Edward GDirector | Dec 31, 2025 | Tax withholding | 89 | $2.77 |
| Shah ChetanDirector | Sep 30, 2025 | Tax withholding | 1,786 | $0.75 |
| Gikakis NicolasDirector | Sep 30, 2025 | Tax withholding | 1,786 | $0.75 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 28,844 | 1.0 | +105.3% |
| Apr 30, 2026 | 14,050 | 1.1 | -60.0% |
| Apr 15, 2026 | 35,087 | 2.9 | +149.7% |
| Mar 31, 2026 | 14,053 | 1.0 | -80.2% |
| Mar 13, 2026 | 70,872 | 1.0 | -18.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMar 17, 2026
- Director / officer change · Amended charter or bylaws · Shareholder voteFeb 23, 2026
- Results of operations · Regulation FD disclosureFeb 12, 2026
- Entered a material agreementJan 26, 2026
- Entered a material agreement · Modified shareholder rights · Regulation FD disclosureDec 8, 2025
- Results of operations · Regulation FD disclosureNov 12, 2025
- Other material eventNov 6, 2025
- Delisting / listing-standard noticeOct 22, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AMay 15, 2026
- 4Apr 21, 2026
- 4Apr 21, 2026
- 4Apr 21, 2026
- 4Apr 21, 2026
- 4Apr 1, 2026
- 4Apr 1, 2026
- 4Apr 1, 2026
- 8-KFORM 8-KMar 17, 2026
- 8-KCURRENT REPORTFeb 23, 2026
- SCHEDULE 13GFeb 17, 2026
- SCHEDULE 13G/AFeb 17, 2026
- 10-QFORM 10-Q FOR DEC 2025Feb 12, 2026
- 8-KCURRENT REPORTFeb 12, 2026
- 424B3FORM 434(B)(3)Jan 27, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.